Document is current
Any future updates will be listed below
-
Authors
Chen, Siyun
Getter, Tamar
Salom, David
Wu, Di https://orcid.org/0000-0001-9748-4408
Quetschlich, Daniel
Chorev, Dror S.
Palczewski, Krzysztof https://orcid.org/0000-0002-0788-545X
Robinson, Carol V. https://orcid.org/0000-0001-7829-5505
- License Information
-
More Information
Article History
Received: 26 August 2021
Accepted: 14 February 2022
First Online: 6 April 2022
Competing interests
: K.P. is Chief Scientific Officer of Polgenix and C.V.R. is a founding director of OMass Therapeutics. All other authors declare no competing interests.
